Alyeska Investment Group
TNYA icon

Alyeska Investment Group’s Tenaya Therapeutics TNYA Stock Holding History

Alyeska Investment Group’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,000,000
Closed -$2.85M – 747
2025
Q4 		$2.85M Buy
+4,000,000
New +$5.44M 0.01% 500
2023
Q1 		– Sell
-1,035,161
Closed -$2.08M – 545
2022
Q4 		$2.08M Buy
+1,035,161
New +$2.53M 0.02% 312

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Alyeska Investment Group's TNYA Position: Q1 2026 in Review

Alyeska Investment Group sold out of Tenaya Therapeutics (TNYA) in Q1 2026, closing a stake of 4,000,000 shares — an estimated $2.85M sold.

Alyeska Investment Group first reported a position in TNYA in Q4 2022 and held it in 2 quarters. The position peaked at $2.85M in Q4 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Alyeska Investment Group reported no remaining Tenaya Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Alyeska Investment Group sold 4,000,000 Tenaya Therapeutics shares in Q1 2026, an estimated $2.85M.
  • Alyeska Investment Group first reported a position in Tenaya Therapeutics in Q4 2022 and held it in 2 quarters.
  • Alyeska Investment Group's Tenaya Therapeutics position peaked at $2.85M in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.